Anti-fouling and specific binding surface, dispersions comprising particles having such surfaces, and methods of making these
Abstract
Disclosed are anti-fouling and optionally specific binding surfaces, methods for forming anti-fouling and optionally specific binding surfaces, and molecules that may be useful for forming anti-fouling and optionally specific binding surfaces. The surfaces may be formed by employing a molecule comprising a poly(2-oxazoline) having functional groups. In an embodiment, the poly(2-oxazoline) comprises a carboxyl endgroup, an amine endgroup, an N- hydroxysuccinimide endgroup, an oxirane endgroup, an oxetane endgroup, or an isocyanate endgroup, which may enable attachment of a specific binding moiety to the poly(2-oxazoline). In an embodiment, the poly(2-oxazoline) molecule comprises a (meth)acrylate functionality that may allow for attachment to a surface comprising a moiety capable of nucleophilic conjugate addition.
Claims
exact text as granted — not AI-modified1 - 18 . (canceled)
21 . A dispersion comprising particles, the surface of the particles comprising a compound according to formula (3):
wherein n is from 2 to 200; R is H or CH 3 ; R 1 comprises a carboxyl endgroup, an amine endgroup, an N-hydroxysuccinimide endgroup, an oxirane endgroup, an oxetane endgroup, an isocyanate endgroup, a tent-butyl carbamate endgroup, a benzyl carbamate endgroup, a phthalimide endgroup, a p-toluenesulfonamide endgroup, a 9-fluorenylmethyl carbamate endgroup, a methyl ester endgroup, a t-butyl ester endgroup, a benzyl ester endgroup, a S-t-butyl ester endgroup, or comprises a specific binding moiety; R 2 is CH 3 or CH 2 CH 3 ; L is an optional linking group; Y is NH, O, or S; Z is NH, O, or S; and X represents the surface of a particle or a group attached to the surface of a particle.
22 . The dispersion according to claim 21 , wherein the particles are magnetic particles.
23 . The dispersion according to claim 21 , wherein the number average molecular weight of the compound according to formula (3), not including the surface of the particle or the group attached to the surface of a particle, is from 500 g/mol to 5,000 g/mol.
24 . The dispersion according to claim 22 , wherein the number average molecular weight of the compound according to formula (3), not including the surface of the particle or the group attached to the surface of a particle, is from 500 g/mol to 5,000 g/mol.
25 . The dispersion according to claim 21 , wherein R 1 comprises a carboxyl endgroup, an amine endgroup, an N-hydroxysuccinimide endgroup, an oxirane endgroup, an oxetane endgroup, or an isocyanate endgroup.
26 . The dispersion according to claim 21 , wherein R 1 comprises a specific binding moiety that has at least one specific binding group, which specific binding group is a functional group capable of binding a desired species or molecule.
27 . The dispersion according to claim 26 , wherein the desired species or molecule is a cell, an antibody, an aptamer, a receptor, a hormone, an enzyme, an oligonucleotide or polynucleotide, synthetic compounds such as drugs or imaging agents, an antigen, a peptide, a fatty acid, a protein, or a characteristic component of bacteria.
28 . The dispersion according to claim 26 , wherein the specific binding group is an antibody, a binding fragment of an antibody, a receptor, a ligand of a receptor, a hormone, a receptor of a hormone, an enzyme, a substrate of an enzyme, a single stranded oligonucleotide, a double stranded oligonucleotide, a single stranded polynucleotide, a double stranded polynucleotide, an antigen, a peptide, a protein, biotin, streptavidin, avidin, neutravidin, or a derivative thereof.
29 . The dispersion according to claim 26 , wherein the specific binding group comprises an adhesive peptide fragment.
30 . The dispersion according to claim 22 , wherein R 1 comprises a specific binding moiety that has at least one specific binding group, which specific binding group is a functional group capable of binding a desired species or molecule.
31 . The dispersion according to claim 30 , wherein the desired species or molecule is a cell, an antibody, an aptamer, a receptor, a hormone, an enzyme, an oligonucleotide or polynucleotide, synthetic compounds such as drugs or imaging agents, an antigen, a peptide, a fatty acid, a protein, or a characteristic component of bacteria.
32 . The dispersion according to claim 30 , wherein the specific binding group is an antibody, a binding fragment of an antibody, a receptor, a ligand of a receptor, a hormone, a receptor of a hormone, an enzyme, a substrate of an enzyme, a single stranded oligonucleotide, a double stranded oligonucleotide, a single stranded polynucleotide, a double stranded polynucleotide, an antigen, a peptide, a protein, biotin, streptavidin, avidin, neutravidin, or a derivative thereof.
33 . The dispersion according to claim 30 , wherein the specific binding group comprises an adhesive peptide fragment.
34 . The dispersion according to claim 21 , wherein the mean particle diameter of the particle is from 1 nm to 10 μm.
35 . The dispersion according to claim 30 , wherein the mean particle diameter of the particle is from 1 nm to 10 μm.
36 . A sensor comprising the dispersion according to claim 21 .
37 . A sensor comprising the dispersion according to claim 35 .
38 . A medical diagnostic device comprising the sensor according to claim 36 .
39 . A tissue culture matrix comprising the dispersion according to claim 22 .
40 . A method comprising the steps of:
a. providing a surface comprising a compound according to formula (3)
wherein n is from 2 to 200; R is H or CH 3 , R 1 comprises a carboxyl endgroup, an amine endgroup, an N-hydroxysuccinimide endgroup, an oxirane endgroup, an oxetane endgroup, or an isocyanate endgroup; R 2 is CH 3 or CH 2 CH 3 ; L is an optional linking group; Y is NH, O, or S; Z is NH, O, or S; and X represents the surface of a magnetic particle or a group attached to the surface of a magnetic particle, and
b. attaching a specific binding moiety to the compound according to formula (3) via the carboxyl, amine, N-hydroxysuccinimide, oxirane, oxetane, or isocyanate endgroup.Join the waitlist — get patent alerts
Track US2021012935A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.